Results 81 to 90 of about 13,106 (252)

Tolerability, Safety, and Pharmacokinetics of Ivermectin After Nasal Application in Healthy Adult Subjects

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Nasal epithelium is the site of infection for SARS‐CoV2 viruses, with interactions of the viral spike protein with the ACE2 receptor of the host cell. Molecular docking studies have shown that ivermectin shields the spike protein and thereby prevents binding to ACE2.
Stefan Wissel   +5 more
wiley   +1 more source

Strongyloidiasis in clinical practice: challenges in diagnostics and treatment (brief review and clinical observations)

open access: yesИнфекция и иммунитет, 2020
High priority of soil-transmitted helminths worldwide and in the Russian Federation is due to their vast distribution and the severe pathological features they induce in humans.
A. K. Tokmalaev   +8 more
doaj   +1 more source

Strongyloidiasis in Africa: Systematic Review and Meta-Analysis on Prevalence, Diagnostic Methods, and Study Settings

open access: yesBioMed Research International, 2020
Background Strongyloidiasis is an intestinal parasitic infection mainly caused by Strongyloides stercoralis. Although it is a predominant parasite in tropics and subtropics where sanitation and hygiene are poorly practiced, the true prevalence of ...
Tadesse Hailu Jember   +3 more
semanticscholar   +1 more source

Epidemiology and Clinical Outcomes of HTLV‐1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Human T‐lymphotropic virus Type 1 (HTLV‐1) is a globally distributed, oncogenic retrovirus endemic in specific regions, including southwestern Japan, sub‐Saharan Africa, the Caribbean, parts of South America (notably Brazil), Iran, and Indigenous communities in Australia. Although most infections are asymptomatic, a minority of carriers develop severe,
Bezhan Noori   +6 more
wiley   +1 more source

Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.

open access: yesPLoS Neglected Tropical Diseases
BackgroundStrongyloides stercoralis is not endemic in Aotearoa New Zealand (AoNZ). However, approximately one third of Auckland residents are born in endemic countries.
Tim Cutfield   +9 more
doaj   +1 more source

Considerations for Screening Live Kidney Donors for Endemic Infections: A Viewpoint on the UNOS Policy [PDF]

open access: yes, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106883/1/ajt12666 ...
Blumberg, E. A.   +9 more
core   +1 more source

Strongyloidiasis in Southern Alicante (Spain): Comparative Retrospective Study of Autochthonous and Imported Cases

open access: yesPathogens, 2020
Background: Strongyloidiasis is a parasitic disease with global prevalence. In Spain, autochthonous cases are concentrated in the Mediterranean basin. We aimed to analyze clinical and epidemiological characteristics of Strongyloides stercoralis infection
Ana Lucas Dato   +11 more
semanticscholar   +1 more source

Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient

open access: yesCase Reports in Transplantation, Volume 2026, Issue 1, 2026.
Donor‐derived Strongyloides stercoralis infection is an uncommon but potentially fatal complication of solid organ transplantation. We describe a case of progression to hyperinfection syndrome with dissemination in a 60‐year‐old woman following orthotopic heart transplantation.
Ana Khazan   +3 more
wiley   +1 more source

Strongyloidiasis in a nonagenarian who previously worked in conservancy services [PDF]

open access: yes, 2013
published_or_final_versio
Chau, KM, Chu, LW, Hung, IFN, Shea, YF
core  

Reply to Bassetti et al. [PDF]

open access: yes, 2005
published_or_final_versio
Ho, PL, Joynt, GM, Yap, FHY
core   +1 more source

Home - About - Disclaimer - Privacy